Advances in radiological staging of non-small cell lung cancer (NSCLC)

Cancer Imaging

Volumn 4, Issue , 2004, Pages S22-S24

  Rankin, S C ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954023151     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2004.0013     Document Type: Article

References (24)

1. Yang SN, Liang JA, Kwan AS, Kao CH, Shen YY. Differentiating benign and malignant pulmonary lesions with FDG-PET. Anticancer Res 2001;21:4153-7.
2. Marom EM, Sarvis S, Herndon JE II, Patz EF Jr. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. Radiology 2002;223:453-9.
3. Ratto GB, Piacenza G, Frola C et al. Chest wall involvement by lung cancer: computed tomographic detection and results of operation. Ann Thorac Surg 1991;51:182-8.
4. Webb WR, Glatsonis C, Zerhouni EA et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178:705-13.
5. Glazer HS, Duncan-Meyer J, Aronberg DJ, Moran JF, Levitt RG, Sagel SS. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation. Radiology 1985;157:191-4.
6. Padovani B, Mouroux J, Seksik L et al. Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging. Radiology 1993;187:33-8.
7. Heelan RT, Demas BE, Caravelli JF et al. Superior sulcus tumours: CT and MRI imaging. Radiology 1989;170:637-41.
8. Glazer HS, Kaiser LR, Anderson DJ et al. Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. Radiology 1989;173:37-42.
9. Arita T, Matsumoto T, Kuramitsu T et al. Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography and nodal specimen. Chest 1996;110:1004-8.
10. Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancers: approaching a controversy using meta-analysis. Am Rev Respir Dis 1990;141:1096-101.
11. Nguyen BC, Stanford W, Thompson BH et al. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma. J Magn Reson Imaging 1999;10:468-73.
12. Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with flurodeoxyglucose in evaluation of small (<1 cm), intermediate (1-3 cm), and large (>3 cm) lymph node lesions. Chest 2000;117:773-8.
13. Steinert HC, Hauser M, Allemann F et al. Non-small cell lung cancer: nodal staging with FDG-PET versus CT with correlative lymph node mapping and sampling. Radiology 1997;202:441-6.
14. Marom EM, McAdams HP, Erasmus JJ et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999;212:803-9.
15. Farrell MA, McAdams HP, Herndon JE, Patz EF Jr. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology 2000;215:886-90.
16. De Leyn P, Vansteenkiste J, Cuypers P et al. Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg 1997;12:706-12.
17. Kernstine KH, Stanford W, Mullan BF et al. PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma. Ann Thorac Surg 1999;68:1022-8.
18. Akhurst T, Downey RJ, Ginsberg MS et al. An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg 2002;73:259-66.
19. Allard P, Yankaskas BC, Fletcher RH, Pargker LA, Halvorsen RA Jr. Sensitivity and specificity of computed tomography for the detection of adrenal metastatic lesions among 91 autopsied lung cancer patients. Cancer 1990;66:457-62.
20. Korobkin M, Brodeur FJ, Yutzy GG et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. Am J Roentgenol 1996;166:531-6.
21. McNicholas MM, Lee MJ, Mayo-Smith WW, Hahn PF, Boland GW, Mueller PR. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. Am J Roentgenol 1995;165:1453-9.
22. Weder W, Schmid RA, Bruchhaus H, Hillinger S, Von Schulthess GK, Steinert HC. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 1998;66:886-93.
23. Seltzer MA, Yap CS, Silverman DH et al. The impact of PET on the management of lung cancer: the referring physician's perspective. J Nucl Med 2002;43:752-6.
24. Kalff V, Hicks RJ, MacManus MP et al. Clinical impact of (18) F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J Clin Oncol 2001;19:111-8.